Lincoln, NE, United States of America

Dennis B Henriksen


Average Co-Inventor Count = 4.9

ph-index = 5

Forward Citations = 58(Granted Patents)


Company Filing History:


Years Active: 1996-2002

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Dennis B Henriksen

Introduction

Dennis B Henriksen is a notable inventor based in Lincoln, NE (US). He has made significant contributions to the field of biotechnology, particularly in the development of recombinant polypeptides. With a total of 9 patents to his name, Henriksen's work has advanced the understanding and application of calcitonin and its analogs.

Latest Patents

Henriksen's latest patents include a recombinant preparation of calcitonin fragments and an enzymatic method for the modification of recombinant polypeptides. The first patent describes a process for the recombinant preparation of a calcitonin fragment linked to a carbonic anhydrase. This innovative method allows for the production of a polypeptide that includes the calcitonin fragment, which can be used in the preparation of calcitonin and related analogs. The second patent outlines a method for modifying recombinant polypeptides at the C-terminal end using a transpeptidation process. This method is versatile and can be applied to recombinant polypeptides from various sources, enhancing their functionality.

Career Highlights

Throughout his career, Henriksen has worked with several prominent companies, including Bionebraska, Inc. and Carlsberg A/S. His experience in these organizations has contributed to his expertise in biotechnology and innovation.

Collaborations

Henriksen has collaborated with notable colleagues such as Fred W Wagner and Jay S Stout. These partnerships have likely fostered a creative environment that has led to significant advancements in their respective fields.

Conclusion

Dennis B Henriksen's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of recombinant polypeptides and their applications in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…